封面
市場調查報告書
商品編碼
1741525

醫用益生菌市場(按成分類型、分銷管道和地區)

Medical Probiotics Market, By Ingredient Type, By Distribution Channel, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 140 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計 2025 年醫用益生菌市場價值將達到 457.6 億美元,到 2032 年將達到 701.8 億美元,2025 年至 2032 年的年複合成長率為 6.3%。

報告範圍 報告詳細資訊
基準年 2024 2025年的市場規模 457.6億美元
效能數據 從2020年到2024年 預測期 2025年至2032年
預測期:2025-2032年年複合成長率: 6.30% 2032年價值預測 701.8億美元

近年來,醫用益生菌因其潛在的健康益處而備受關注。益生菌是對人體,尤其是消化器官系統有益的活菌和酵母。它們天然存在於優格和酸菜等發酵食品中。而醫用益生菌則經過特殊配製,旨在提供針對性的健康益處。

全球醫用益生菌市場正在快速成長,這得益於人們日益重視腸道健康、慢性病盛行率上升以及對天然和預防性保健解決方案的需求不斷成長等因素。醫用益生菌以促進消化和增強免疫系統而聞名,使其成為傳統藥物的極具吸引力的替代品。

市場動態:

預計醫用益生菌市場在預測期內將顯著成長。該市場的主要促進因素包括消費者對天然和預防性保健產品的需求不斷成長、慢性病盛行率不斷上升,以及人們對腸道健康與整體健康之間聯繫的理解日益加深。

然而,也存在一些阻礙市場成長的因素。主要挑戰之一是缺乏關於醫用益生菌使用和標籤的標準化法規,這導致消費者和醫療保健專業人員對這些產品的功效和安全性缺乏信心。此外,醫用益生菌價格高昂,在某些地區供應有限,也可能阻礙市場成長。

儘管面臨這些挑戰,醫用益生菌市場仍存在著許多成長機會。益生菌相關研發活動的不斷增加、益生菌產品生產和行銷技術的進步以及醫用益生菌應用領域的不斷拓展,都是推動市場成長的一些因素。

本研究的主要特點

  • 本報告對全球醫用益生菌市場進行了詳細分析,包括預測期(2025-2032 年)的市場規模和年複合成長率(CAGR%),以 2024 年為基準年。
  • 它揭示了各個領域的潛在商機,並說明了該市場的引人注目的投資提案矩陣。
  • 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
  • 本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
  • 全球醫用益生菌市場報告迎合了該行業的各個相關人員,包括投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
  • 相關人員將透過用於分析全球醫用益生菌市場的各種策略矩陣更輕鬆地做出決策。

目錄

第1章 調查目的與前提條件

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告描述
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章市場動態、法規與趨勢分析

  • 市場動態
    • 驅動程式
  • 女性保健產品上市數量增加
    • 限制因素
  • 研發成本高且監管嚴格
    • 機會
  • 設施擴建
  • 主要亮點
  • 監管情景
  • 近期動態
  • 產品發布/核准
  • PEST分析
  • 波特分析
  • 合併、收購和合作

第4章 醫用益生菌市場-冠狀病毒(COVID-19)大流行的影響

  • COVID-19流行病學
  • 供需側分析
  • 經濟影響

5. 醫用益生菌市場(依成分類型),2020 年至 2032 年

  • 細菌
  • 乳酸菌
  • 雙歧桿菌
  • 鏈球菌
  • 芽孢桿菌
  • 酵母菌
  • 孢子形成者
  • 其他

6. 醫用益生菌市場(按應用分類),2020 年至 2032 年

  • 益生菌食品飲料
  • 乳製品
  • 非乳製品飲料
  • 序列
  • 烘焙點心
  • 發酵肉品肉製品
  • 益生菌膳食補充劑
  • 益生菌對女性健康的作用
  • 嬰兒奶粉
  • 其他

7. 醫用益生菌市場(依通路分類),2020 年至 2032 年

  • 大賣場/超級市場
  • 藥局/藥局
  • 專賣店
  • 網上銷售

8. 醫用益生菌市場(按地區分類),2020 年至 2032 年

  • 北美洲
      • 美國
      • 加拿大
  • 歐洲
      • 德國
      • 英國
      • 西班牙
      • 俄羅斯
      • 義大利
      • 法國
      • 其他歐洲國家
  • 亞太地區
      • 中國
      • 印度
      • 日本
      • 韓國
      • 澳洲
      • ASEAN
      • 其他亞太地區
  • 拉丁美洲
      • 阿根廷
      • 巴西
      • 墨西哥
      • 其他拉丁美洲
  • 中東
      • 海灣合作理事會國家
      • 以色列
      • 其他中東地區
  • 非洲
      • 南非
      • 北非
      • 中部非洲

第9章 競爭態勢

  • 公司簡介
    • Probi AB
    • Abbott
    • Lonza
    • Hansen Holding A/S
    • Danone SA
    • Yakult Honsha Co., Ltd.
    • Nestle SA
    • DowDuPont Inc.
    • Kerry Group plc
    • BioGaia AB
    • DSM
    • Sun Genomics
    • Evonik
    • Probiotics International Limited(Protexin)
    • UAS Laboratories LLC
  • 分析師觀點

第 10 章 章節

  • 參考
  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI6438

Medical Probiotics Market is estimated to be valued at USD 45.76 Bn in 2025 and is expected to reach USD 70.18 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.3% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 45.76 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 6.30% 2032 Value Projection: USD 70.18 Bn

Medical probiotics have gained significant attention in recent years due to their potential health benefits. Probiotics are live bacteria and yeasts that are beneficial for the human body, especially the digestive system. They are found naturally in foods like yogurt, sauerkraut, and other fermented products. Medical probiotics, on the other hand, are specifically formulated to provide targeted health benefits.

The global medical probiotics market is growing rapidly, driven by factors such as the increasing awareness about the importance of gut health, rising prevalence of chronic diseases, and the growing demand for natural and preventive healthcare solutions. Medical probiotics are known to support digestion and boost the immune system, making them an attractive alternative to traditional medicines.

Market Dynamics:

The medical probiotics market is expected to witness significant growth during the forecast period. The key drivers of this market include the increasing consumer demand for natural and preventive healthcare options, the rising incidence of chronic diseases, and the growing understanding of the link between gut health and overall well-being.

However, there are also certain restraints that may hinder the market growth. One of the major challenges is the lack of standardized regulations governing the use and labeling of medical probiotics. This leads to a lack of confidence among consumers and healthcare professionals regarding the efficacy and safety of these products. Additionally, the high cost of medical probiotics and the limited availability of products in certain regions may also impede market growth.

Despite these challenges, the medical probiotics market presents several opportunities for growth. The increasing research and development activities related to probiotics, advancements in technology for the production and delivery of probiotic products, and the expanding application areas of medical probiotics are some of the factors driving market growth.

Key Features of the Study:

  • This report provides in-depth analysis of the global medical probiotics market, including market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • Key companies covered as a part of this study include Probi AB, Chr. Hansen Holding A/S, Danone S.A., Yakult Honsha Co., Ltd., Nestle S.A., DowDuPont Inc., Kerry Group plc, BioGaia AB, Probiotics International Limited (Protexin), and UAS Laboratories LLC.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global medical probiotics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global medical probiotics market.

Medical Probiotics Market Segmentation:

  • By Ingredient Type
    • Bacteria
    • Lactobacilli
    • Bifidobacterium
    • Streptococcus
    • Bacillus
    • Yeast
    • Spore Formers
    • Others
  • By Application
    • Probiotic Food & Beverages
    • Dairy Products
    • Non-dairy Beverages
    • Cereals
    • Baked Goods
    • Fermented Meat Products
    • Probiotic Dietary Supplements
    • Animal Feed Probiotics
    • Probiotics for Women's Health
    • Infant Formula
    • Others
  • By End user
    • Human Probiotics
    • Animal Probiotics
  • By Distribution Channel
    • Hypermarkets/Supermarkets
    • Pharmacies/Drugstores
    • Specialty Stores
    • Online Sales
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and Africa
  • Company Profiles
    • Probi AB
    • Hansen Holding A/S
    • Danone S.A.
    • Yakult Honsha Co., Ltd.
    • Nestle S.A.
    • DowDuPont Inc.
    • Kerry Group plc
    • BioGaia AB
    • Probiotics International Limited (Protexin)
    • UAS Laboratories LLC

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Ingredient Type
    • Market Snippet, By Application
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Increasing product launches for women's health
    • Restraints
  • High R&D costs and stringent regulations
    • Opportunities
  • Facility expansion
  • Key Highlights
  • Regulatory Scenario
  • Recent Trends
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Mergers, Acquisitions, and Collaborations

4. Medical Probiotics Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Medical Probiotics Market, By Ingredient Type, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Bacteria
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Lactobacilli
  • Bifidobacterium
  • Streptococcus
  • Bacillus
  • Yeast
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Spore Formers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Medical Probiotics Market, By Application, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021- 2032
    • Segment Trends
  • Probiotic Food & Beverages
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Dairy Products
  • Non-dairy Beverages
  • Cereals
  • Baked Goods
  • Fermented Meat Products
  • Probiotic Dietary Supplements
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Probiotics for Women's Health
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Infant Formula
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Medical Probiotics Market, By Distribution Channel, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021- 2032
    • Segment Trends
  • Hypermarkets/Supermarkets
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Pharmacies/Drugstores
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mon)
  • Specialty Stores
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Online Sales
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Medical Probiotics Market, By Region, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Sub-region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Sub-region, 2021-2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Ingredient Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Ingredient Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • Germany
      • U.K.
      • Spain
      • Russia
      • Italy
      • France
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Ingredient Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • China
      • India
      • Japan
      • South Korea
      • Australia
      • ASEAN
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Ingredient Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • Argentina
      • Brazil
      • Mexico
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Ingredient Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2020-2032,(US$ Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Ingredient Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • South Africa
      • North Africa
      • Central Africa

9. Competitive Landscape

  • Company Profile
    • Probi AB
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
    • Abbott
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
    • Lonza
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
    • Hansen Holding A/S
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Danone S.A.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Yakult Honsha Co., Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Nestle S.A.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • DowDuPont Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Kerry Group plc
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • BioGaia AB
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • DSM
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Sun Genomics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Evonik
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Probiotics International Limited (Protexin)
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • UAS Laboratories LLC
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Analysts' Views

10. Section

  • References
  • Research Methodology
  • About us